Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.7 |
mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.7 |
mRNA | 681640 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |